How much does a box of Merck’s Belzutifan targeted drug cost? Pricing and Patient Purchasing Reference

Belzutifan (trade name: Welireg) is the first HIF-2α inhibitor developed by Merck (Merck) and is mainly used to treat Von Renal cell carcinoma (RCC) associated with Hippel-Lindau syndrome (VHL), central nervous system hemangioblastoma (CNS hemangioblastoma) and pancreatic neuroendocrine tumors (pNET). The drug was approved for marketing by the U.S. FDA in August 2021. The recommended dose is Daily 120mg, usually one bottle per month (40mg×90 capsules).

In the United States,Belzutifan is priced quite high. According to public information, each bottle (40mg In addition, the price of the "commercial version" provided by some channels is even as high as 31.2 RMB. Since Belzutifan has not yet been officially launched in mainland China, patients cannot purchase it through domestic hospitals or pharmacies. Therefore, some patients choose to obtain the drug through overseas medical service institutions or cross-border drug purchasing platforms.

For patients with limited budgets, Lao generic drugs offer a more economical option. For example, the Belzutifan generic drug (40mg The ingredients of this generic drug are basically the same as the original drug, and it has been approved by the health department in Laos. However, patients should be cautious when choosing generic drugs to ensure that the drugs are from regular sources and used under the guidance of professional doctors.

To sum up, bezutivan is priced higher in the United States, and generic drugs in Laos offer a more economical alternative. Since the drug is not yet available in mainland China, patients need to obtain it through overseas channels. During the purchase and use process, patients are advised to consult professional medical institutions or doctors to ensure the safety and efficacy of the medication.

Reference materials:https://www.welireg.com/